LV10490B - Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins - Google Patents

Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins Download PDF

Info

Publication number
LV10490B
LV10490B LVP-93-376A LV930376A LV10490B LV 10490 B LV10490 B LV 10490B LV 930376 A LV930376 A LV 930376A LV 10490 B LV10490 B LV 10490B
Authority
LV
Latvia
Prior art keywords
protein
cusi
plasmid
pro
husi
Prior art date
Application number
LVP-93-376A
Other languages
English (en)
Latvian (lv)
Other versions
LV10490A (lv
Inventor
Heinzel Regina
Appelhans Heribert
Gassen Hans-G Nther
Machleidt Werner
Seemeller Ursula
Original Assignee
Grenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grenenthal Gmbh filed Critical Grenenthal Gmbh
Publication of LV10490A publication Critical patent/LV10490A/xx
Publication of LV10490B publication Critical patent/LV10490B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
LVP-93-376A 1986-01-10 1993-05-18 Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins LV10490B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863600571 DE3600571A1 (de) 1986-01-10 1986-01-10 Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
LV10490A LV10490A (lv) 1995-02-20
LV10490B true LV10490B (en) 1995-10-20

Family

ID=6291649

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-376A LV10490B (en) 1986-01-10 1993-05-18 Dna sequences coding for proteins having biological activity of husi-i type inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins

Country Status (16)

Country Link
US (1) US4845076A (un)
EP (1) EP0232523B1 (un)
JP (2) JP2533869B2 (un)
AT (1) ATE88500T1 (un)
AU (1) AU604003B2 (un)
CA (1) CA1326216C (un)
DE (2) DE3600571A1 (un)
DK (1) DK11187A (un)
ES (1) ES2054612T3 (un)
HU (1) HU204888B (un)
IE (1) IE61526B1 (un)
IL (1) IL81221A0 (un)
LT (1) LTIP1753A (un)
LV (1) LV10490B (un)
PT (1) PT84089B (un)
ZA (1) ZA87141B (un)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
US5851983A (en) * 1987-12-28 1998-12-22 Teijin Limited Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
US6869925B1 (en) * 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
HUT75660A (en) * 1994-03-23 1997-05-28 Tokyo Tanabe Co Novel remedy for respiratory-tract viral disease
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase
EP1400247A1 (en) * 1999-07-01 2004-03-24 Reprogen, Inc. Treatment of endometriosis with antileukoprotease
US6544740B1 (en) 1999-07-01 2003-04-08 Reprogen, Inc. Treatment of endometriosis with antileukoprotease
US7247704B2 (en) * 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
AU2002325108A1 (en) * 2001-08-27 2003-03-10 Les Laboratoires Aeterna Inc. Serine protease inhibitor and processes for the preparation thereof
GB2532488B (en) * 2014-11-21 2019-07-31 Univ Of The Western Cape Use of AMP1 or AMP8 to diagnose HIV infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591474B2 (en) * 1984-12-06 1989-12-07 Amgen, Inc. Serine protease inhibitors and methods for isolation of same
AU590238B2 (en) * 1984-12-06 1989-11-02 Amgen, Inc. Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン　バイオロジカルズ，インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物

Also Published As

Publication number Publication date
ZA87141B (en) 1987-08-26
DE3600571A1 (de) 1987-08-06
AU604003B2 (en) 1990-12-06
JP2659525B2 (ja) 1997-09-30
LV10490A (lv) 1995-02-20
US4845076A (en) 1989-07-04
HU204888B (en) 1992-02-28
DE3688324D1 (de) 1993-05-27
IL81221A0 (en) 1987-08-31
JP2533869B2 (ja) 1996-09-11
JPS62259591A (ja) 1987-11-11
IE61526B1 (en) 1994-11-16
ES2054612T3 (es) 1994-08-16
PT84089B (pt) 1989-02-28
DK11187A (da) 1987-07-11
AU6745287A (en) 1987-07-16
ATE88500T1 (de) 1993-05-15
JPH07300500A (ja) 1995-11-14
IE870055L (en) 1987-07-10
EP0232523A3 (en) 1988-12-07
HUT43106A (en) 1987-09-28
LTIP1753A (en) 1995-07-25
CA1326216C (en) 1994-01-18
EP0232523B1 (de) 1993-04-21
EP0232523A2 (de) 1987-08-19
PT84089A (en) 1987-02-01
DK11187D0 (da) 1987-01-09

Similar Documents

Publication Publication Date Title
US4845076A (en) DNA sequences coding for proteins having the biological activity of HUSI-type I inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
US5824505A (en) Vectors, transformed cells and process for the preparation of hirudin
Heinzel et al. Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus
EP0621871B1 (en) A human kunitz-type protease inhibitor variant
US5464822A (en) Polypeptides and polypeptide analogues
JPH07506334A (ja) ヒトＫｕｎｉｔｚ型プロテアーゼ阻害剤変異体
JPH07504891A (ja) ヒトクニッツ型プロテアーゼインヒビターの変異体
HUT70291A (en) A novel human kunitz-type protease inhibitor and variants thereof
JPH08504568A (ja) ウシ膵トリプシン阻害因子から誘導される因子ＶＩＩａ−組織因子複合体の阻害因子
AU625018B2 (en) Variants of pai-2
AU632361B2 (en) Recombinant aprotinin variants - genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
CA1341165C (en) Active site modified protease alpha-1-antitrypsin inhibitors and their production
US5705355A (en) Hirudin, pharmaceutical compositions comprising it and their use
CA2134240C (en) Novel peptide having elastase inhibitor activity and process for producing the same
AU2004225718B2 (en) Inhibitor proteins of a protease and use thereof
KR980009283A (ko) 특성이 개선된 아프로티닌 변이체
AU705267B2 (en) Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural N-terminal sequence
US5231010A (en) Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
JPS61501609A (ja) ヒルジンの発現のためのベクタ−、形質転換細胞及びヒルジンの製造方法
Cook et al. Expression and Purification of Recombinant Tick Anticoagulant Peptide (Y1W/D10R) Double Mutant Secreted bySaccharomyces cerevisiae
CA1340971C (en) Metalloproteinase inhibitor sequence recombinant vector system for using the same and recombinant-dna method for the manufacture of same
JPH09124700A (ja) 新規プロテアーゼインヒビターおよびその製造方法、エラスターゼが関与する疾患の治療剤